These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6606219)

  • 41. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
    Veerhuis R; Van Es LA; Daha MR
    Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
    Späth P; Berchtold P; Engler H; Bütler R
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1373-5. PubMed ID: 6593823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of fibronectin to Clq; inhibition of binding by aggregated IgG.
    Harris C; Roth S; Schmid FR; Anderson B
    Immunol Commun; 1981; 10(7):601-9. PubMed ID: 6800936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
    Carter SD; Scott DL; Elson CJ
    Br J Rheumatol; 1986 Nov; 25(4):353-8. PubMed ID: 3490895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The [125I]C1q binding assay for the detection of soluble immune complexes.
    Zubler RH; Carpentier N; Lambert PH
    Methods Enzymol; 1981; 74 Pt C():530-7. PubMed ID: 6976503
    [No Abstract]   [Full Text] [Related]  

  • 49. Fibronectin binding to C1q associated with antigen-antibody complexes in EDTA-treated plasma.
    Sorvillo J; Gigli I; Pearlstein E
    Scand J Immunol; 1986 Feb; 23(2):153-60. PubMed ID: 3081998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
    Wener MH; Uwatoko S; Mannik M
    Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus.
    Abdou NI; Wall H; Lindsley HB; Halsey JF; Suzuki T
    J Clin Invest; 1981 May; 67(5):1297-304. PubMed ID: 6971876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iodination of mono- and heteroclonal immunoglobulin G with lactoperoxidase and chloramine T.
    Prenzel KD; Thönes S; Havsteen BH
    Hoppe Seylers Z Physiol Chem; 1977 Nov; 358(11):1483-9. PubMed ID: 411728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absorbance nephelometry of C1q-precipitable immune complexes: method comparisons and clinical correlations.
    Levinson SS; Goldman J
    Clin Chem; 1983 Dec; 29(12):2082-6. PubMed ID: 6605819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.
    Hällgren R; Wide L
    Ann Rheum Dis; 1976 Aug; 35(4):306-13. PubMed ID: 788651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
    Taylor RP; Horgan C; Hooper M; Burge J
    J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
    Wager O; Lindstrøm P
    Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.